Onyx Healthcare vs Veeva Systems Inc Class A: Fair Value & Quality
Both stocks run through our valuation models. Here is how Onyx Healthcare (6569) and Veeva Systems Inc Class A (VEEV) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees Onyx Healthcare as the less overvalued of the two: Onyx Healthcare trades at TWD 95.00 versus a fair value of TWD 43.29 (-54%), while Veeva Systems Inc Class A trades at $230 versus $95.12 (-59%).
Onyx Healthcare
6569.TWO · TWD · Health Care
-54%
upside to fair value
overvalued
PriceTWD 95.00
Fair ValueTWD 43.29
Quality64/100
Veeva Systems Inc Class A
VEEV · USD · Health Care
-59%
upside to fair value
overvalued
Price$230
Fair Value$95.12
Quality72/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Onyx HealthcareVeeva Systems Inc Class A
Valuation
35.0×P/E (TTM)33.6×
2.84×P/S (TTM)9.31×
2.50×P/B4.28×
35.4×EV/EBITDA28.7×
—PEG0.85×
2.5%Dividend yield—
TWD 2.50Dividend per share—
Profitability
11%Net margin28%
8%Operating margin31%
9%Return on equity14%
3%Return on assets7%
Growth
22%Revenue growth (YoY)16%
-6.4%Avg. growth/yr (3Y)14.0%
-0.5%Avg. growth/yr (5Y)16.9%
Balance & size
0.07×Debt / equity—
$122MMarket cap$31B
weakGrowth qualityhealthy
Veeva Systems Inc Class A leads: 3 to 8 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Onyx Healthcareof which business quality 64 · market factors 40Veeva Systems Inc Class Aof which business quality 72 · market factors 48
ProfitabilityMargins and returns on capital today
39
57
Quality GrowthAre margins and returns improving?
42
65
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
88
33
Low VolatilityCalm price path (market factor)
74
55
MomentumPrice trend over the last 3–12 months (market factor)
34
52
52W MomentumDistance to the 52-week high (market factor)
14
31
Net IssuanceBuybacks instead of dilution
70
72
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Onyx Healthcare
DCF ModelsTWD 43.12
Earnings-BasedTWD 18.66
MultiplesTWD 40.66
Asset-BasedTWD 26.93
Growth DCFTWD 44.53
Economic ProfitTWD 23.60
Growth EarningsTWD 47.69
22 of 22 models see the stock below the current price.
Veeva Systems Inc Class A
DCF Models$214
Earnings-Based$142
Dividend Discount$0.41
Multiples$93.60
Asset-Based$29.76
Growth DCF$200
Economic Profit$57.47
Growth Earnings$185
21 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Onyx Healthcare
Bear TWD 36.59Fair Value TWD 43.29Bull TWD 51.82
TWD 95.00 = current price (white tick)
Veeva Systems Inc Class A
Bear $71.34Fair Value $95.12Bull $146
$230 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Onyx Healthcare · Health Care
Quality score64 · Top 25%
Fair value upside-54% · below median
Veeva Systems Inc Class A · Health Care
Quality score72 · Top 25%
Fair value upside-59% · below median
Bottom line
As of Aug 11, 2026, Fair Value Calculator sees Onyx Healthcare as the less overvalued of the two: Onyx Healthcare trades at TWD 95.00 versus a fair value of TWD 43.29 (-54%), while Veeva Systems Inc Class A trades at $230 versus $95.12 (-59%).
Veeva Systems Inc Class A has the higher quality score (72/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
